These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 25616974
1. Lower maximum standardized uptake value of fluorine-18 fluorodeoxyglucose positron emission tomography coupled with computed tomography imaging in pancreatic ductal adenocarcinoma patients with diabetes. Chung KH, Park JK, Lee SH, Hwang DW, Cho JY, Yoon YS, Han HS, Hwang JH. Am J Surg; 2015 Apr; 209(4):709-16. PubMed ID: 25616974 [Abstract] [Full Text] [Related]
3. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography. Ergul N, Gundogan C, Tozlu M, Toprak H, Kadıoglu H, Aydin M, Cermik TF. Rev Esp Med Nucl Imagen Mol; 2014 Apr; 33(3):159-64. PubMed ID: 24140024 [Abstract] [Full Text] [Related]
5. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature. Guan ZW, Xu BX, Wang RM, Sun L, Tian JH. Hell J Nucl Med; 2013 Apr; 16(2):97-102. PubMed ID: 23687644 [Abstract] [Full Text] [Related]
7. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT. Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [Abstract] [Full Text] [Related]
10. Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase imaging to identify intraductal papillary mucinous neoplasm. Saito M, Ishihara T, Tada M, Tsuyuguchi T, Mikata R, Sakai Y, Tawada K, Sugiyama H, Kurosawa J, Otsuka M, Uchida Y, Uchiyama K, Miyazaki M, Yokosuka O. Clin Gastroenterol Hepatol; 2013 Feb; 11(2):181-6. PubMed ID: 23142206 [Abstract] [Full Text] [Related]
13. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses. Tsuboyama T, Tatsumi M, Onishi H, Nakamoto A, Kim T, Hori M, Sakane M, Hori Y, Morii E, Hatazawa J, Tomiyama N. Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584 [Abstract] [Full Text] [Related]
18. Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions. Dong A, Cui Y, Gao L, Wang Y, Zuo C, Yang J. Abdom Imaging; 2014 Feb; 39(1):175-86. PubMed ID: 24136586 [Abstract] [Full Text] [Related]
20. Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas. Kitasato Y, Yasunaga M, Okuda K, Kinoshita H, Tanaka H, Okabe Y, Kawahara A, Kage M, Kaida H, Ishibashi M. Pancreas; 2014 Oct; 43(7):1060-5. PubMed ID: 25121413 [Abstract] [Full Text] [Related] Page: [Next] [New Search]